DexCom Inc
DXCM· Nasdaq
DXCMDexCom Inc
Filed Feb 14, 2022 · 10-K · 45 days after period end · 0001093557-22-000014
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $698.20M | $568.90M | $462.80M | $338.00M |
| Net Income | -$5.30M | $411.30M | $92.70M | -$179.70M |
| EPS Diluted | — | — | $1.00 | -$2.03 |
DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Feb 14, 2022 · 45 d after period end
